A new research study at UCLA aims to re-define prostate cancer significance through clinical validation of a tool which allows 3D visualization and tracking of the prostate. By fusing multi-parametric MRI (T2-weighted, diffusion-weighted imaging, dynamic contrast enhancement) with real-time ultrasound, suspicious areas seen on the MRI can be tracked and targeted during prostate biopsy. This research aims to improve currently available methods of cancer diagnosis.
Video: Targeted Prostate Biopsy using MR-Ultrasound Fusion
Prostate Biopsy: Targeted Prostate Biopsy MR-Ultrasound Fusion at UCLA
Targeted biopsy is now being used at UCLA to diagnose prostate cancer
News Release:
New technology fuses MRI, ultrasound to achieve targeted biopsy of prostate cancer
